These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. State-dependent inhibition of inactivation-deficient Ca(V)1.2 and Ca(V)2.3 channels by mibefradil. Bernatchez G, Sauvé R, Parent L. J Membr Biol; 2001 Nov 15; 184(2):143-59. PubMed ID: 11719851 [Abstract] [Full Text] [Related]
9. Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine. Furukawa T, Nukada T, Suzuki K, Fujita Y, Mori Y, Nishimura M, Yamanaka M. Br J Pharmacol; 1997 Jul 15; 121(6):1136-40. PubMed ID: 9249249 [Abstract] [Full Text] [Related]
10. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5. Perchenet L, Clément-Chomienne O. J Pharmacol Exp Ther; 2000 Nov 15; 295(2):771-8. PubMed ID: 11046117 [Abstract] [Full Text] [Related]
11. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. Rossier MF, Ertel EA, Vallotton MB, Capponi AM. J Pharmacol Exp Ther; 1998 Dec 15; 287(3):824-31. PubMed ID: 9864260 [Abstract] [Full Text] [Related]
12. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart. Emanuel K, Mackiewicz U, Pytkowski B, Lewartowski B. J Physiol Pharmacol; 1998 Dec 15; 49(4):577-90. PubMed ID: 10069698 [Abstract] [Full Text] [Related]